Literature DB >> 22262182

Autoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.

Tung O Chan1, John M Pascal, Roger S Armen, Ulrich Rodeck.   

Abstract

AGC kinases, including the three Akt (protein kinase B) isoforms, protein kinase A (PKA) and all protein kinase C (PKC) isoforms, require activation loop phosphorylation (threonine 308 in Akt1) as well as phosphorylation of a C-terminal residue (serine 473 in Akt1) for catalytic activity and phosphorylation of downstream targets. Conversely, phosphatases reverse these phosphorylations. Virtually all cellular processes are affected by AGC kinases, a circumstance that has led to intense scrutiny of the molecular mechanisms that regulate phosphorylation of these kinases. Here, we review a new layer of control of phosphorylation in Akt, PKA and PKC pointing to ATP binding pocket occupancy as a means to decelerate dephosphorylation of these and, potentially, other kinases. This additional level of kinase regulation opens the door to search for new functional motifs for the rational design of non- ATP-competitive kinase inhibitors that discriminate within and between protein kinase families.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262182      PMCID: PMC3315091          DOI: 10.4161/cc.11.3.19059

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  32 in total

1.  Detection of conformational changes along the kinetic pathway of protein kinase A using a catalytic trapping technique.

Authors:  J Shaffer; J A Adams
Journal:  Biochemistry       Date:  1999-09-14       Impact factor: 3.162

Review 2.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

3.  The hallmark of AGC kinase functional divergence is its C-terminal tail, a cis-acting regulatory module.

Authors:  Natarajan Kannan; Nina Haste; Susan S Taylor; Andrew F Neuwald
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-16       Impact factor: 11.205

4.  A role for K-ras in conferring resistance to the MEK inhibitor, CI-1040.

Authors:  Yuli Wang; Keri Van Becelaere; Ping Jiang; Sally Przybranowski; Charles Omer; Judith Sebolt-Leopold
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

5.  3-D structure and dynamics of protein kinase B-new mechanism for the allosteric regulation of an AGC kinase.

Authors:  Véronique Calleja; Michel Laguerre; Banafshé Larijani
Journal:  J Chem Biol       Date:  2009-02-20

Review 6.  AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation.

Authors:  T O Chan; S E Rittenhouse; P N Tsichlis
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

7.  Dephosphorylation of PKCdelta by protein phosphatase 2Ac and its inhibition by nucleotides.

Authors:  Jyoti Srivastava; Jozef Goris; Stephen M Dilworth; Peter J Parker
Journal:  FEBS Lett       Date:  2002-04-10       Impact factor: 4.124

8.  Enhanced dephosphorylation of cAMP-dependent protein kinase by oxidation and thiol modification.

Authors:  Kenneth M Humphries; Michael S Deal; Susan S Taylor
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

9.  Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.

Authors:  Michele T Yip-Schneider; Patrick J Klein; Sabrina C Wentz; Amer Zeni; Alex Menze; C Max Schmidt
Journal:  J Pharmacol Exp Ther       Date:  2009-03-03       Impact factor: 4.030

10.  Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.

Authors:  Jeffrey F Ohren; Huifen Chen; Alexander Pavlovsky; Christopher Whitehead; Erli Zhang; Peter Kuffa; Chunhong Yan; Patrick McConnell; Cindy Spessard; Craig Banotai; W Thomas Mueller; Amy Delaney; Charles Omer; Judith Sebolt-Leopold; David T Dudley; Iris K Leung; Cathlin Flamme; Joseph Warmus; Michael Kaufman; Stephen Barrett; Haile Tecle; Charles A Hasemann
Journal:  Nat Struct Mol Biol       Date:  2004-11-14       Impact factor: 15.369

View more
  7 in total

1.  Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity.

Authors:  Qingming Dong; Francesco Giorgianni; Xiong Deng; Sarka Beranova-Giorgianni; Dave Bridges; Edwards A Park; Rajendra Raghow; Marshall B Elam
Journal:  Biochem Biophys Res Commun       Date:  2014-05-20       Impact factor: 3.575

2.  A tripartite cooperative mechanism confers resistance of the protein kinase A catalytic subunit to dephosphorylation.

Authors:  Tung O Chan; Roger S Armen; Santosh Yadav; Sushrut Shah; Jin Zhang; Brian C Tiegs; Nikhil Keny; Brian Blumhof; Deepak A Deshpande; Ulrich Rodeck; Raymond B Penn
Journal:  J Biol Chem       Date:  2020-01-21       Impact factor: 5.157

3.  Heat shock proteins regulate activation-induced proteasomal degradation of the mature phosphorylated form of protein kinase C.

Authors:  Michelle A Lum; Gregor M Balaburski; Maureen E Murphy; Adrian R Black; Jennifer D Black
Journal:  J Biol Chem       Date:  2013-07-30       Impact factor: 5.157

4.  Akt kinase C-terminal modifications control activation loop dephosphorylation and enhance insulin response.

Authors:  Tung O Chan; Jin Zhang; Brian C Tiegs; Brian Blumhof; Linda Yan; Nikhil Keny; Morgan Penny; Xue Li; John M Pascal; Roger S Armen; Ulrich Rodeck; Raymond B Penn
Journal:  Biochem J       Date:  2015-07-22       Impact factor: 3.857

Review 5.  New insights into the functions and localization of the homeotic gene CDX2 in gastric cancer.

Authors:  Lin-Hai Yan; Wei-Yuan Wei; Yu-Bo Xie; Qiang Xiao
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

6.  Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway.

Authors:  Sophie Trefely; Poh-Sim Khoo; James R Krycer; Rima Chaudhuri; Daniel J Fazakerley; Benjamin L Parker; Ghazal Sultani; James Lee; Jean-Philippe Stephan; Eric Torres; Kenneth Jung; Coenraad Kuijl; David E James; Jagath R Junutula; Jacqueline Stöckli
Journal:  J Biol Chem       Date:  2015-09-04       Impact factor: 5.157

7.  An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer.

Authors:  Jing Xu; Yi Gao; Xiaotian Luan; Ke Li; Jing Wang; Yilin Dai; Mingyi Kang; Chong Lu; Minhua Zhang; Chris X Lu; Yu Kang; Congjian Xu
Journal:  Cancer Chemother Pharmacol       Date:  2022-04-13       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.